Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
Conditions: Glioma; Glioblastoma Multiforme Intervention: Drug: APG-157 Sponsor: Aveta Biomics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials